Maravai LifeSciences Holdings, Inc. (MRVI)
$7.44+3.19%Close
BUYCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.1B
- Beta
- 0.60
- P/E (TTM)
- -14.66
- Short % float
- 13.67%
- Days to cover
- 5.9
- SI change
- +11.8%
- 1W
- -5.82%
- 1M
- +10.55%
- vs SPY 1W
- -6.98%
- vs SPY 1M
- +7.56%
Industry peers
FMP comparable companies · ranked by market cap
- IOVABUYIovance Biotherapeutics, Inc.$6.3BRECOVERYQ 9$14.15+9.84%
- VIRBUYVir Biotechnology, Inc.$2.0BBULLQ 13$11.78+5.22%
- SEPNSELLSepterna Inc$1.7BRECOVERYQ 28$37.87+3.98%
- TYRASELLTyra Biosciences, Inc.$1.2BCRISISQ 5$20.93-0.15%
- BCAXSELLBicara Therapeutics Inc. Common Stock$1.1BCRISISQ -9$17.29+1.39%
- REPLSELLReplimune Group, Inc.$1.1BRECOVERYQ 14$13.15+2.91%
- DNABUYGinkgo Bioworks Holdings, Inc.$979MRECOVERYQ -16$14.98+14.64%
- KURASELLKura Oncology, Inc.$943MBEARQ 12$10.62+0.76%
- PRMEBUYPrime Medicine, Inc.$580MRECOVERYQ -6$3.21+11.45%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on MRVI?
- LOPJLB’s latest quantitative signal on Maravai LifeSciences Holdings, Inc. (MRVI) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is MRVI in?
- Maravai LifeSciences Holdings, Inc. (MRVI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Maravai LifeSciences Holdings, Inc. (MRVI) do?
- Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody…